ENTPD1 and cancer: Using mass cytometry and T cell receptor (TCR) sequencing of colorectal and lung cancer specimens, CD39 expression was enriched in CD8 tumor infiltrating lymphocytes (TILs) that possessed cancer antigen specificity (47).